Phase
Condition
Presbyopia
Astigmatism
Treatment
Clareon Vivity IOL - Toric
Clareon PanOptix Trifocal IOL - Non Toric
Clareon Vivity IOL - Non Toric
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Key Inclusion Criteria:
Subject or legally authorized representative must be able to understand and sign anapproved Informed Consent Form.
Subject must have had bilateral implantation of Clareon Vivity, Clareon VivityToric, Clareon PanOptix, or Clareon PanOptix Toric IOLs between 3-6 months prior toenrollment.
Subject must have a documented medical history and required pre-operative baselineinformation available for retrospective data collection.
Other protocol-defined inclusion criteria may apply.
Exclusion
Key Exclusion Criteria:
Subject is currently participating in another investigational drug or device study.
Subject has had corneal refractive surgery after Clareon Vivity, Clareon VivityToric, Clareon PanOptix, or Clareon PanOptix Toric IOL implantation.
Subject is pregnant at the time of enrollment.
Other protocol-defined exclusion criteria may apply.
Study Design
Study Description
Connect with a study center
Centro Oftalmologico Metropolitano
San Juan, 00921
Puerto RicoActive - Recruiting
Wolstan & Goldberg Eye Associates
Torrance, California 90505
United StatesActive - Recruiting
Levenson Eye Associates
Jacksonville, Florida 32204
United StatesActive - Recruiting
Eye Surgeons of CNY
Liverpool, New York 13088
United StatesActive - Recruiting
Tulsa Ophthalmology
Tulsa, Oklahoma 74104
United StatesActive - Recruiting
Chu Eye Institute
Fort Worth, Texas 76107
United StatesActive - Recruiting
Contact Alcon Call Center for Trial Locations
Fort Worth, Texas 76134
United StatesSite Not Available
The Eye Institute of Utah
Salt Lake City, Utah 84107
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.